Prostate delineation using CT and MRI for radiotherapy patients with bilateral hip prostheses

Radiotherapy and Oncology

Volumn 90, Issue 3, 2009, Pages 325-330

  Rosewall, Tara ^a,b   Kong, Vickie ^a,b   Vesprini, Danny ^a,b   Catton, Charles ^a,b   Chung, Peter ^a,b   Ménard, Cynthia ^a,b   Bayley, Andrew ^a,b  

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Hip replacement; Image registration; Prostate cancer; Radiotherapy; Target definition

Indexed keywords

ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; EXTERNAL BEAM RADIOTHERAPY; HIP PROSTHESIS; HUMAN; IMAGE ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSTATE CANCER; THREE DIMENSIONAL IMAGING; TUMOR VOLUME;

HIP PROSTHESIS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; OBSERVER VARIATION; ORGAN SIZE; PROSTATE; PROSTATIC NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 61349143046     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2008.11.015     Document Type: Article

References (41)

1. Ding G.X., and Yu C.W. A study on beams passing through hip prosthesis for pelvic radiation treatment. Int J Radiat Oncol Biol Phys 51 (2001) 1167-1175
2. Buffard E., Gschwind R., Makovick L., et al. Study of the impact of artificial articulations on the dose distribution under medical irradiation. Nucl Instrum Methods Phys Res 229 (2005) 78-84
3. Carolan M., Dao P., Fox C., et al. Effect of hip prostheses on radiotherapy dose. Aust Radiol 44 (2000) 290-295
4. Mesbahi A., and Nejad F.S. Dose attenuation effect of hip prostheses in a 9-MV photon beam: commercial treatment planning system versus Monte Carlo calculations. Radiat Med 25 (2007) 529-535
5. Buffard E., Gschwind R., Makovick L., et al. Monte Carlo calculations of the impact of a hip prosthesis on the dose distribution. Nucl Instum Methods Phys Res 251 (2006) 9-18
6. Eng T.Y. Dose attenuation through a titanium alloy hip prosthesis. Med Dosim 25 (2000) 7-8
7. Lin S.Y., Chu T.C., Lin J.P., et al. The effect of a metal hip prosthesis on the radiation dose in therapeutic photon beam irradiations. Appl Radiat Isot 57 (2002) 17-23
8. Keall P.J., Siebers J.V., Jeraj R., et al. Radiotherapy dose calculations in the presence of hip prostheses. Med Dosim 28 (2003) 107-112
9. Reft C., Alecu R., Das I.J., et al. Dosimetric considerations for patients with HIP prostheses undergoing pelvic irradiation. Report of the AAPM Radiation Therapy Committee Task Group 63. Med Phys 30 (2003) 1162-1182
10. Schild S.E., Robinow J.S., Casale H.E., et al. Radiotherapy treatment planning for prostate cancer in patients with prosthetic hips. Med Dosim 17 (1992) 83-86
11. James L. Prostate irradiation in patients with hip prostheses - a retrospective analysis. J Radiother Practice 5 (2006) 147-156
12. Agapito J. Radical radiation therapy for carcinoma of the prostate in patients with a single hip prosthesis: a technique analysis using dose--volume histograms. Med Dosim 26 (2001) 243-250
13. Kong V., Rosewall T., Catton C., et al. Optimal technique for dose-escalated radiotherapy to the prostate gland in patients with bilateral hip prostheses. Radiother Oncol 88 Suppl 2 (2008) S449
14. Kung J.H., Reft H., Jackson W., et al. Intensity-modulated radiotherapy for a prostate patient with a metal prosthesis. Med Dosim 26 (2001) 305-308
15. Su A., Reft C., Rash C., et al. A case study of radiotherapy planning for a bilateral metal hip prosthesis prostate cancer patient. Med Dosim 30 (2005) 169-175
16. Fiorino C., Reni M., Bolognesi A., et al. Intra- and inter-observer variability in contouring prostate and seminal vesicles: implications for conformal treatment planning. Radiother Oncol 47 (1998) 285-292
17. Berthelet E., Liu M.C., Agranovich A., et al. Computed tomography determination of prostate volume and maximum dimensions: a study of interobserver variability. Radiother Oncol 63 (2002) 37-40
18. Roach III M., Faillace-Akazawa P., Malfatti C., et al. Prostate volumes defined by magnetic resonance imaging and computerized tomographic scans for three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys 35 (1996) 1011-1018
19. Milosevic M., Voruganti S., Blend R., et al. Magnetic resonance imaging (MRI) for localization of the prostatic apex: comparison to computed tomography (CT) and urethrography. Radiother Oncol 47 (1998) 277-284
20. Rasch C., Barillot I., Remeijer P., et al. Definition of the prostate in CT and MRI: a multi-observer study. Int J Radiat Oncol Biol Phys 43 (1999) 57-66
21. Khoo V.S., Padhani A.R., Tanner S.F., et al. Comparison of MRI with CT for the radiotherapy planning of prostate cancer: a feasibility study. Br J Radiol 72 (1999) 590-597
22. Parker C.C., Damyanovich A., Haycocks T., et al. Magnetic resonance imaging in the radiation treatment planning of localized prostate cancer using intra-prostatic fiducial markers for computed tomography co-registration. Radiother Oncol 66 (2003) 217-224
23. Nichol A.M., Brock K.K., Lockwood G.A., et al. A magnetic resonance imaging study of prostate deformation relative to implanted gold fiducial markers. Int J Radiat Oncol Biol Phys 67 (2007) 48-56
24. Gao Z., Wilkins D., Eapen L., et al. A study of prostate delineation referenced against a gold standard created from the visible human data. Radiother Oncol 85 (2007) 239-246
25. Yazdia M., Gingras L., and Beaulieu L. An adaptive approach to metal artifact reduction in helical computed tomography for radiation therapy treatment planning: experimental and clinical studies. Int J Radiat Oncol Biol Phys 62 (2005) 1224-1231
26. Coolens C., and Childs P.J. Calibration of CT Hounsfield units for radiotherapy treatment planning of patients with metallic hip prostheses: the use of the extended CT-scale. Phys Med Biol 48 (2003) 1591-1603
27. Aubin M., Morin O., Chen J., et al. The use of megavoltage cone-beam CT to complement CT for target definition in pelvic radiotherapy in the presence of hip replacement. Br J Radiol 79 (2006) 918-921
28. Debois M., Oyen R., Maes F., et al. The contribution of magnetic resonance imaging to the three-dimensional treatment planning of localized prostate cancer. Int J Radiat Oncol Biol Phys 45 (1999) 857-865
29. Charnley N., Morgan A., Thomas E., et al. The use of CT-MR image registration to define target volumes in pelvic radiotherapy in the presence of bilateral hip replacements. Br J Radiol 78 (2005) 634-636
30. Moseley D.J., White E.A., Wiltshire K.L., et al. Comparison of localization performance with implanted fiducial markers and cone-beam computed tomography for on-line image-guided radiotherapy of the prostate. Int J Radiat Oncol Biol Phys 67 (2007) 942-953
31. Wu J., Haycocks T., Alasti H., et al. Positioning errors and prostate motion during conformal prostate radiotherapy using on-line isocentre set-up verification and implanted prostate markers. Radiother Oncol 61 (2001) 127-133
32. Katti K.S. Biomaterials in total joint replacement. Colloids Surf B Biointerfaces 39 (2004) 133-142
33. Altman D. Practical statistics for medical research. 8th ed. vol. 1 (1997), Chapman & Hall/CRC, London
34. Krempien R.C., Schubert K., Zierhut D., et al. Open low-field magnetic resonance imaging in radiation therapy treatment planning. Int J Radiat Oncol Biol Phys 53 (2002) 1350-1360
35. Fidelman N.A., Wilson M.W., Bloom A.I., et al. Orthopedic spinal and hip prostheses: effects of magnetic susceptibility artifacts during MR arteriography and venography of abdomen and pelvis. Radiology 240 (2006) 894-899
36. Kolind S.H., MacKay A.L., Munk P.L., et al. Quantitative evaluation of metal artifact reduction techniques. J Magn Reson Imaging 20 (2004) 487-495
37. Mechlin M., Thickman D., Kressel H.Y., et al. Magnetic resonance imaging of postoperative patients with metallic implants. AJR Am J Roentgenol 143 (1984) 1281-1284
38. Augustiny N., von Schulthess G.K., Meier D., et al. MR imaging of large nonferromagnetic metallic implants at 1.5 T. J Comput Assist Tomogr 11 (1987) 678-683
39. Eustace S., Goldberg R., Williamson D., et al. MR imaging of soft tissues adjacent to orthopaedic hardware: techniques to minimize susceptibility artefact. Clin Radiol 52 (1997) 589-594
40. Lemmens J.A., van Horn J.R., den Boer J., et al. MR imaging of 22 Charnley-Muller total hip prostheses. Rofo 145 (1986) 311-315
41. Valicenti R.K., Sweet J.W., Hauck W.W., et al. Variation of clinical target volume definition in three-dimensional conformal radiation therapy for prostate cancer. Int J Radiat Oncol Biol Phys 44 (1999) 931-935